The NF-κB pathway was recently reported to be situated downstream of the SLC/CCR7 axis in hepatocellular carcinoma and downstream of the TGF-β1/TGF-βR axis in prostate cancer [21, 22]. This evidence concerns the gene CCL21 and Familial prostate cancer.